Akari Therapeutics, Plc AKTX
7.80 USD -1.49 (-16.04%)
Nov 5, 2026, 12:54 PM EST
7.79 Day range 9.03
3.02 52-week range 29.32
- YTD
- -32.53%
- 1 year
- -71.57%
Ownership
Held by insiders 11.91%
Held by institutions 0.51%
Float held by institutions 0.58%
Institutions 11
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Omnia Family Wealth, LLC | 0.33% | 87,628 | 85.88K | Sep 29, 2024 |
| Citadel Advisors Llc | 0.13% | 33,260 | 32.59K | Sep 29, 2024 |
| Cerity Partners LLC | 0.09% | 23,643 | 23.17K | Sep 29, 2024 |
| Renaissance Technologies, LLC | 0.07% | 18,069 | 17.71K | Sep 29, 2024 |
| Cresset Asset Management, LLC | 0.07% | 18,408 | 18.04K | Sep 29, 2024 |
| Cornerstone Planning Group LLC | 0.00% | 5 | 4 | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.01% | 1,512 | 1.48K | Oct 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DICICCO WENDY FRANCES | Chief Financial Officer | Stock Award(Grant) | Apr 30, 2024 | 158,474,000 |
| PATEL SAMIR RASHMIKANT | Director | Stock Award(Grant) | Jun 27, 2024 | 3,502,890,000 |
| PRUDO-CHLEBOSZ RAYMOND M.D. | Director | Stock Award(Grant) | Dec 1, 2024 | 4,916,600,000 |